Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction
埃洛妥珠单抗介导的抗体依赖性细胞毒性作用(ADCC)可激活Th1样Vγ9Vδ2 T细胞,从而破坏骨髓瘤细胞与破骨细胞的相互作用。
期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16401
Inoue, Yusuke; Tenshin, Hirofumi; Teramachi, Jumpei; Sumitani, Ryohei; Oda, Asuka; Maeda, Yusaku; Oura, Masahiro; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Hara, Tomoyo; Endo, Itsuro; Kagawa, Kumiko; Ozaki, Shuji; Hiasa, Masahiro; Harada, Takeshi; Abe, Masahiro
DCC
T细胞
T细胞
骨髓瘤
细胞生物学
毒理研究
免疫/内分泌